Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|16|1940-1962

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.16, 2016-12, pp. : 1940-1962

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present)

By Magrioti Victoria   Kokotos George  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 333-344

Informa Healthcare

Access to resources Recommend Favorite

Novel Therapeutic Targets for Somatostatin in Inflammatory Chronic Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 1, 2005-02 ,pp. : 91-104

Bentham Science Publishers

Access to resources Recommend Favorite

Rho GTPases as therapeutic targets for the treatment of inflammatory diseases

By Zhao Dezheng   Pothoulakis Charalabos  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 583-592

Informa Healthcare

Access to resources Recommend Favorite

Selectins as Targets in Inflammatory Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 1, 2004-03 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite

Exploring DNA Topoisomerases as Targets of Novel Therapeutic Agents in the Treatment of Infectious Diseases

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 1, 2007-03 ,pp. : 3-9

Bentham Science Publishers

Access to resources Recommend Favorite